Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Share-Based Compensation

v3.22.1
Stockholders' Equity and Share-Based Compensation
3 Months Ended
Apr. 02, 2022
Stockholders' Equity and Share-Based Compensation  
Stockholders' Equity and Share-Based Compensation

Note 3 – Stockholders’ Equity and Share-Based Compensation

Options and Restricted Stock Units

The Company had the following common stock option activity during the thirteen weeks ended April 2, 2022:

Granted options to purchase 0 common shares.
Exercise of 533 options to purchase common shares.
Forfeiture of 17 options to purchase common shares.
Expiration of 1 options to purchase common shares.

The following table summarizes the Company’s restricted stock unit ("RSU") activity for the thirteen weeks ended April 2, 2022, and details regarding the awards outstanding and exercisable as of April 2, 2022 (in thousands):

Weighted

Weighted Average

Average

Grant Date

Aggregate

    

Shares

    

Exercise Price

    

Fair Value

    

Intrinsic Value

Vested and expected to vest as of January 1, 2022

3,023

 

$

Awarded

1,142

 

$

Vested

(516)

 

$

Forfeited

(2)

 

$

Awards outstanding, April 2, 2022

3,647

 

$

$

11.53

 

$

24,436

Vested and expected to vest as of April 2, 2022

3,647

 

$

$

11.53

 

$

24,436

During the thirteen weeks ended April 2, 2022, 62 RSUs that vested were time-based and 454 were performance-based.

For the thirteen weeks ended April 2, 2022, we recorded compensation costs related to stock options and RSUs of $4,306, of which $81 related to common shares issued to consultants as part of their compensation for services provided during the period. For the thirteen weeks ended April 3, 2021, we recorded compensation costs related to stock options and RSUs of $4,080. As of April 2, 2022, there was unrecognized compensation expense related to stock options and RSUs of $36,087 that will be expensed through March 2026.